MTT assay of the PTEN-overexpressed neuroblastoma cells showed decreased proliferation at the 72-hour time point in SPARC-inhibited cells to 70%, 62% and 75% in SK-N-AS, NB1691 and IMR-32 cells, respectively (Fig. 6B). The gene discussed is SPARC; the disease is neuroblastoma.